| Grčević D, Kušec R, Kovačić N, et al.
Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes. [JOURNAL ARTICLE]
Leuk Res 2009 Nov 17.
Abstract | Full Citation | | Krejci M, Adam Z, Buchler T, et al.
Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myeloma. [JOURNAL ARTICLE]
Ann Hematol 2009 Nov 19.
Abstract | Full Citation | Find Related Articles | | Belardo G, Piva R, Santoro MG
Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells. [JOURNAL ARTICLE]
Leukemia 2009 Nov 19.
Abstract | Full Citation | Find Related Articles | | Perez LE, Parquet N, Mead M, et al.
Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma. [JOURNAL ARTICLE]
Eur J Haematol 2009 Nov 17.
Abstract | Full Citation | | Kim YK, Sohn SK, Lee JH, et al.
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study. [JOURNAL ARTICLE]
Ann Hematol 2009 Nov 18.
Abstract | Full Citation | Find Related Articles | | Bensinger WI, Jagannath S, Vescio R, et al.
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma. [JOURNAL ARTICLE]
Br J Haematol 2009 Nov 16.
Abstract | Full Citation | | Orciuolo E, Buda G, Pelosini M, et al.
Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma. [JOURNAL ARTICLE]
Br J Haematol 2009 Nov 16.
Full Citation | | Waterhouse DF, Moloney GA, Gargoum FS, et al.
Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report. [Journal Article]
Cases J 2009.:7456.
Abstract | Full Citation | Find Related Articles | | Belloni D, Veschini L, Foglieni C, et al.
Bortezomib induces autophagic death in proliferating human endothelial cells. [JOURNAL ARTICLE]
Exp Cell Res 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Moschetta M, Di Pietro G, Ria R, et al.
Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. [JOURNAL ARTICLE]
Eur J Cancer 2009 Nov 12.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
